Nasdaq12d
Citigroup Downgrades Tandem Diabetes Care (LSE:0M0F)
Fintel reports that on March 4, 2025, Citigroup downgraded their outlook for Tandem Diabetes Care (LSE:0M0F) from Buy to Neutral. There are 601 funds or institutions reporting positions in Tandem ...
AOL16d
Citigroup’s $81 trillion mistake is a warning ‘that operational risk is still a ticking time bomb in banking,’ expert says
Citigroup accidentally credited a customer account $81 trillion instead of $280 last April. It took three employees and several hours to realize and correct the error ...
Hims & Hers Health’s (HIMS) Sell Rating Reiterated at Citigroup
Citigroup reiterated their sell rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $27.00 price ...
Citi Remains a Buy on GE Healthcare Technologies Inc (GEHC)
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report). The ...
Morningstar26d
Sabra Health Care REIT, Inc. to Attend Citi’s 2025 Global Property CEO Conference and the 2025 NIC Spring Conference
Sabra Health Care REIT, Inc. (Nasdaq ... the company’s Executive Vice President of Finance, will attend Citi’s 2025 Global Property CEO Conference on March 3-5, 2025 at The Diplomat Beach ...
Sabra Health Care REIT, Inc. to Attend Citi’s 2025 Global Property CEO Conference and the 2025 NIC Spring Conference
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, ...